Not available
Quote | Avinger Inc. (NASDAQ:AVGR)
Last: | $1.74 |
---|---|
Change Percent: | -4.73% |
Open: | $1.77 |
Close: | $1.74 |
High: | $1.7899 |
Low: | $1.71 |
Volume: | 5,798 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Avinger Inc. (NASDAQ:AVGR)
$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 17, 2024 / Avinger, Inc. (NASDAQ:AVGR) , a commercial-stage medical device company developing and mar...
2024-06-14 09:24:30 ET More on Avinger Seeking Alpha’s Quant Rating on Avinger Historical earnings data for Avinger Financial information for Avinger Read the full article on Seeking Alpha For further details see: Avinger announces pricing ...
Message Board Posts | Avinger Inc. (NASDAQ:AVGR)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $AVGR News Article - Leading Data on the Treatment of In-Stent Restenosis with Pantheri | whytestocks | investorshangout | 04/28/2023 12:05:47 PM |
$AVGR what do you make of this data? | georgie18 | investorshub | 04/27/2023 11:15:21 PM |
$AVGR Time for a bounce? | peterus | investorshub | 04/27/2023 5:20:12 PM |
$AVGR Price gaining | Nelson2 | investorshub | 04/27/2023 10:01:53 AM |
$AVGR got some short data | Zardiw | investorshub | 04/27/2023 5:25:28 AM |
News, Short Squeeze, Breakout and More Instantly...
$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 17, 2024 / Avinger, Inc. (NASDAQ:AVGR) , a commercial-stage medical device company developing and mar...
$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 14, 2024 / Avinger, Inc. (NASDAQ:AVGR) , a commercial-stage medical device company developing and mar...
REDWOOD CITY, CA / ACCESSWIRE / June 5, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced that it will incre...